Overview

A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)

Status:
Completed

Trial end date:
2017-07-21

Target enrollment:

Participant gender:

Summary

The primary objective of the study was to investigate the efficacy of mirabegron versus placebo in male patients with OAB symptoms while taking the alpha blocker, tamsulosin, for BPH.

Phase:

Phase 4

Details

Lead Sponsor:

Astellas Pharma Inc

Collaborator:

Astellas Pharma Singapore Pte. Ltd.

Treatments:

Adrenergic alpha-Antagonists
Mirabegron
Tamsulosin